NEW CASES

FULLY
EQUIPPED

SHAREHOLDER CLASS ACTION FILED AGAINST CONCORDIA INTERNATIONAL CORP. - CXRX

Notice is hereby given that a class action lawsuit has been filed on behalf of those who purchased or otherwise acquired shares of Concordia International Corp. (NASDAQ:CXRX) (TSX:CXR) (“Concordia” or the “Company”) between November 12, 2015 and August 12, 2016, inclusive (the “Class Period”).

Concordia investors may receive additional information about the case by clicking the link "Join this Class Action" above. 

Concordia is a specialty pharmaceutical company that owns a portfolio of branded and generic prescription products.  The Company’s prescription products are sold to wholesalers, hospitals and pharmacies in over 100 countries.

The shareholder class action complaint alleges that Concordia and certain of its executive officers made a series of false and misleading statements and/or failed to disclose material adverse information to investors during the Class Period, including the following:  (1) that the Company was experiencing a substantial increase in market competition against Donnatal and other products; (2) that, as a result, the Company’s financial results would suffer and it would be forced to suspend its dividend; and (3) that, as a result of the foregoing, the defendants’ statements about Concordia’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

On August 12, 2016, Concordia announced that it was lowering its 2016 guidance “to reflect the impact of unexpected competition on several products … and current foreign currency exchange rates.” Concordia also announced that its Chief Financial Officer would be “leaving the organization to pursue other opportunities” and that its Board of Directors had suspended the Company’s quarterly dividend.

Following this news, shares of the Company’s stock declined $6.23 per share, or over 38%, to close on August 12, 2016 at $10.13 per share, on unusually heavy trading volume.

If you are a member of the class described above, you may no later than October 14, 2016, move the Court to serve as lead plaintiff of the class, if you so choose. 

A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation.  In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class.  Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Any member of the purported class may move the court to serve as a lead plaintiff through counsel of their choice, or may choose to do nothing and remain an inactive class member.

Kessler Topaz Meltzer & Check, LLP has not filed a complaint in this matter.  If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP toll free at 1-888-299-7706 or 1-610-667-7706, or via e-mail at info@ktmc.com.

CONTACT:
Kessler Topaz Meltzer & Check, LLP
James Maro, Esq. or Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087 1-888-299-7706 (toll free) or 1-610-667-7706
Or by e-mail at info@ktmc.com

Please complete this form and list your purchase and sale transaction(s) for Concordia International Corp. (NASDAQ:CXRX) (TSX:CXR)  between November 12, 2015 and August 12, 2016, inclusive (the “Class Period”):

Information Sheet
* Denotes required field
Acquisitions
Date Aquired
Number of Shares Acquired
Acquisition Price Per Share
Sales
Date Sold
Number of Shares Sold
Selling Price Per Share
Did you purchase shares of Concordia International Corp. prior to the class period?
Area you a current or former employee of Concordia International Corp. ?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
How did you hear about this case?
Sign Up for Monthly Update: